Side-by-side comparison of AI visibility scores, market position, and capabilities
SF healthcare integration platform ('Segment + Zapier for healthcare') syncing patient data across clinical tools for 10K+ patients; YC S22 $3.5M Kindred Ventures-backed serving mental health and chronic care tech-enabled providers.
Morf Health is a San Francisco-based healthcare data integration and workflow automation platform — backed by Y Combinator (S22) with $3.5 million raised including a $3 million seed round led by Kindred Ventures in November 2023, with participation from Uncommon Ventures and Asymmetric Capital — providing tech-enabled healthcare providers (virtual mental health practices, nutrition programs, chronic disease management companies, and preventive care platforms) with an integration and automation layer that synchronizes patient data across their clinical and operational tools stack, described as 'Segment plus Zapier for healthcare.' Founded in 2022 and having onboarded 10,000+ patients through integrated workflows, Morf addresses the data fragmentation problem that plagues digital health companies operating across 5-15 specialized clinical tools that don't natively integrate.
Chicago medical imaging and AI diagnostics (NASDAQ: GEHC) ~$19.7B FY2024 revenue; GE spinoff Jan 2023, Edison AI 100+ models, 4M+ installed devices, Alzheimer's PET tracer competing with Siemens Healthineers.
GE HealthCare Technologies Inc. is a Chicago, Illinois-based medical technology and digital health company — publicly traded on the NASDAQ (NASDAQ: GEHC) as an S&P 500 Health Care component — designing, manufacturing, and servicing medical imaging systems, patient monitoring equipment, pharmaceutical diagnostics, and AI-powered clinical decision support software through approximately 51,000 employees in 160 countries. GE HealthCare was spun off from General Electric Company in January 2023 — one of the most significant healthcare demergers in history — and has operated as an independent public company building its own capital structure, R&D investment priorities, and operational identity separate from GE's industrial conglomerate structure. In fiscal year 2024, GE HealthCare reported revenues of approximately $19.7 billion, with its four business segments contributing: Imaging (MRI, CT, X-ray, molecular imaging — ~$9.1B), Ultrasound (~$3.0B), Patient Care Solutions (monitoring, anesthesia — ~$3.6B), and Pharmaceutical Diagnostics (PET/SPECT contrast agents — ~$2.6B). CEO Peter Arduini has prioritized accelerating GE HealthCare's AI integration across its imaging portfolio — the Edison AI platform (100+ AI models cleared or in development for radiology workflows) embeds AI-assisted detection, workflow optimization, and image quality enhancement into GE HealthCare scanners, positioning the company as a digital health platform rather than a hardware manufacturer.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.